IQVIA Launches First Technology-Enabled COVID-19 Trial Matching Solution within the U.S. to Accelerate Treatment and Vaccine Development
IQVIA Holdings, Inc. (IQV)
Last iqvia holdings, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.iqvia.com
Company Research
Source: Business Wire
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA™ (NYSE: IQV), a leader in Human Data Science, today announced its new technology-enabled COVID-19 Trial Matching Tool at c19trials.com, which is one of the world’s first online platforms that matches individuals with specific COVID-19 studies to accelerate clinical research projects.“In response to this unprecedented crisis, IQVIA has created the first comprehensive online screener and trial matching tool for all U.S. COVID-19 trials,” said Richard Staub, president, Research & Development Solutions at IQVIA. “This sponsor-agnostic solution will accelerate Phase I-IV clinical research trials when they are most needed, by connecting users to COVID-19 investigators working tirelessly to discover, and develop treatments and vaccines against this disease. IQVIA is focused on delivering industry-leading clinical development solutions to support and advance human health on behalf of our valued customers.”The IQVIA COVI
Show less
Read more
Impact Snapshot
Event Time:
IQV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IQV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IQV alerts
High impacting IQVIA Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
IQV
News
- IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform [Yahoo! Finance]Yahoo! Finance
- IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI PlatformBusiness Wire
- IQVIA (NYSE:IQV) was given a new $265.00 price target on by analysts at Morgan Stanley.MarketBeat
- IQVIA (NYSE:IQV) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=IQV&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from a "MarketBeat
- ODAIA Adds Senior Pharma and AI Leaders to Accelerate Growth and Industry Adoption [Yahoo! Finance]Yahoo! Finance
IQV
Earnings
- 10/28/25 - Beat
IQV
Sec Filings
- 11/14/25 - Form 3
- 11/7/25 - Form 4
- 11/7/25 - Form 4
- IQV's page on the SEC website